NCT06521229Active, not recruiting
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
An Ambispective Observational Multicenter Registry of Patients With Uncontrolled Asthma in the Population of the Russian Federation
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
This study is a multi-centre, non-interventional, observational, ambispective registry. Planned study population consists of 9 000 adult patients with uncontrolled asthma receiving treatment according to standard of care (except biologics). Planned number of study site is 70 outpatient centers with experience of uncontrolled asthma treatment in about 50 regions of Russia (in order to describe characteristics of patients with uncontrolled asthma in different regions in the most comprehensive way).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 9000 (estimated)
- First submitted
- 21 Jun 2024
- Start date
- 27 Jun 2024
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- AstraZeneca
- Diseases
- Asthma
- NCT number
- NCT06521229
What you commit to
- Study type: Observational
- Planned participants: 9000
- From 27 Jun 2024 to the primary completion date, 30 Sept 2026
- 44 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with severe asthma or/and patients receiving any biological therapy currently or within 52 weeks prior to inclusion;
- The participation in any clinical study currently or within 52 weeks prior to inclusion;
Other illness
- Presence of chronic obstructive pulmonary disease (COPD) or idiopathic pulmonary fibrosis (ILF) currently or in the anamnesis;
- An acute or chronic disease that, as deemed by Investigator, limits the ability of patients to participate in this study or could influence the interpretation of the results.
Who the study is looking for
- Age ≥ 18 years at the time of inclusion;
- Signed and dated written informed consent in accordance with ICH GCP and local law prior to inclusion in the study;
- Patients with diagnosis of uncontrolled mild and moderate asthma (according to Global Initiative for Asthma (GINA) score);
- Patients with the availability of at least 52 weeks of follow-up data (prior to inclusion) in the medical records.
Sex: All · Does not accept healthy volunteers
Sites (44)
Sites in registry order. Pick your city on the disease page to sort them by distance.
This page is information, not medical advice. Discuss any trial with your doctor.